The 0.1% Portrait of Human History

Stored in the human genome, perhaps, is the record of human evolution and existence on this planet. Many say, however, that this history and the benefits it may unfold for human health cannot be found in the single, essentially complete human sequence--99.9% similar to any other human sequence. It's the 0.1% difference that should tell the tale--not only of migration, war, technological achievement, and conquest--but also of the differences that confer susceptibility to complex, multigenic dis

Written byBrendan Maher
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Stored in the human genome, perhaps, is the record of human evolution and existence on this planet. Many say, however, that this history and the benefits it may unfold for human health cannot be found in the single, essentially complete human sequence--99.9% similar to any other human sequence. It's the 0.1% difference that should tell the tale--not only of migration, war, technological achievement, and conquest--but also of the differences that confer susceptibility to complex, multigenic diseases.

In piecing together the travails of diverse human populations, geneticists use a growing number of tools and technologies. But, what would arguably be the most valuable resource to population geneticists still does not exist. First envisioned a decade ago, a project to sample diverse populations on a global scale faltered in its planning stages amid controversy and criticism that its proponents were not sensitive to the concerns of groups it proposed to study. Its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies